Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes

European Journal of Pharmacology

Volumn 490, Issue 1-3, 2004, Pages 187-197

  Sima, Anders A F ^a,b,c   Kamiya, Hideke ^a,b   Li, Zhen Guo ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

C peptide; CNS complication; Hyperglycemia; Insulin; Type 1 and type 2 diabetes

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN;

APOPTOSIS; BRAIN ISCHEMIA; CELL LOSS; COGNITIVE DEFECT; DIABETIC NEUROPATHY; DIABETOGENESIS; DISEASE EXACERBATION; DNA STRUCTURE; ELECTROPHYSIOLOGY; ENDOPLASMIC RETICULUM; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; HUMAN; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; INSULIN SYNTHESIS; INTERMETHOD COMPARISON; NERVE CELL GROWTH; NERVE CELL PLASTICITY; NEUROPSYCHOLOGY; NEUROTRANSMITTER RELEASE; NICK END LABELING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; SEROTONIN BRAIN LEVEL; SPECIES COMPARISON; STREPTOZOCIN DIABETES;

EID: 1842785176     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.02.056     Document Type: Article

References (150)

1. Aggarwal B.B. Apoptosis and nuclear factor-kappa B: a tale of association and dissociation. Biochem. Pharmacol. 60:2000;1033-1039.
2. Araki Y., Nomura M., Tanaka H., Yamamoto H., Yamamoto T., Tsukaguchi I., Nakamura H. MRI of the brain in diabetes mellitus. Neuroradiology. 36:1994;101-103.
3. Bannerman D.M., Good M.A., Butcher S.P., Ramsay M., Morris R.G. Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature. 378:1995;182-186.
4. Barber M., Kasturi B.S., Austin M.E., Patel K.P., MohanKumar S.M., MohanKumar P.S. Diabetes-induced neuroendocrine changes in rats: role of brain monoamines, insulin and leptin. Brain Res. 964:2003;128-135.
5. Barr P.J., Tomei L.D. Apoptosis and its role in human disease. Biotechnology (NY). 12:1994;487-493.
6. Barrett-Connor E., Khaw K.T. Diabetes mellitus: an independent risk factor for stroke? Am. J. Epidemiol. 128:1988;116-123.
7. Bertrand F., Desbois-Mouthon C., Cadoret A., Prunier C., Robin H., Capeau J., Atfi A., Cherqui G. Insulin antiapoptotic signaling involves insulin activation of the nuclear factor kappaB-dependent survival genes encoding tumor necrosis factor receptor-associated factor 2 and manganese-superoxide dismutase. J. Biol. Chem. 274:1999;30596-30602.
8. Bestetti G., Rossi G.L. Hypothalamic lesions in rats with long-term streptozotocin-induced diabetes mellitus. A semiquantitative light- and electron-microscopic study. Acta Neuropathol. (Berl.). 52:1980;119-127.
9. Bestetti G., Rossi G.L. Hypothalamic changes in diabetic Chinese hamsters. A semiquantitative, light and electron microscopic study. Lab. Invest. 47:1982;516-522.
10. Biessels G.J., Kamal A., Ramakers G.M., Urban I.J., Spruijt B.M., Erkelens D.W., Gispen W.H. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes. 45:1996;1259-1266.
11. Biessels G.J., Kamal A., Urban I.J., Spruijt B.M., Erkelens D.W., Gispen W.H. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res. 800:1998;125-135.
12. Biessels G.J., Cristino N.A., Rutten G.J., Hamers F.P., Erkelens D.W., Gispen W.H. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. Brain. 122(Pt. 4):1999;757-768.
13. Blanz B.J., Rensch-Riemann B.S., Fritz-Sigmund D.I., Schmidt M.H. IDDM is a risk factor for adolescent psychiatric disorders. Diabetes Care. 16:1993;1579-1587.
14. Bours V., Bentires-Alj M., Hellin A.C., Viatour P., Robe P., Delhalle S., Benoit V., Merville M.P. Nuclear factor-kappa B, cancer, and apoptosis. Biochem. Pharmacol. 60:2000;1085-1089.
15. Britton M., Rafols J., Alousi S., Dunbar J.C. The effects of middle cerebral artery occlusion on central nervous system apoptotic events in normal and diabetic rats. Int. J. Exp. Diabetes Res. 4:2003;13-20.
16. Cao G., Pei W., Lan J., Stetler R.A., Luo Y., Nagayama T., Graham S.H., Yin X.M., Simon R.P., Chen J. Caspase-activated DNase/DNA fragmentation factor 40 mediates apoptotic DNA fragmentation in transient cerebral ischemia and in neuronal cultures. J. Neurosci. 21:2001;4678-4690.
17. Ceriello A., Quatraro A., Giugliano D. Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. Diabetologia. 36:1993;265-266.
18. Chakrabarti S., Zhang W.X., Sima A.A.F. Optic neuropathy in the diabetic BB-rat. Adv. Exp. Med. Biol. 291:1991;257-264.
19. Charriaut-Marlangue C., Remolleau S., Aggoun-Zouaoui D., Ben-Ari Y. Apoptosis and programmed cell death: a role in cerebral ischemia. Biomed. Pharmacother. 52:1998;264-269.
20. Chen J., Nagayama T., Jin K., Stetler R.A., Zhu R.L., Graham S.H., Simon R.P. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18:1998;4914-4928.
21. Comi G. Evoked potentials in diabetes mellitus. Clin. Neurosci. 4:1997;374-379.
22. Cracco J., Castells S., Mark E. Spinal somatosensory evoked potentials in juvenile diabetes. Ann. Neurol. 15:1984;55-58.
23. Deary I.J., Crawford J.R., Hepburn D.A., Langan S.J., Blackmore L.M., Frier B.M. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes. 42:1993;341-344.
24. de Courten-Myers G.M., Xi G., Hwang J.H., Dunn R.S., Mills A.S., Holland S.K., Wagner K.R., Myers R.E. Hypoglycemic brain injury: potentiation from respiratory depression and injury aggravation from hyperglycemic treatment overshoots. J. Cereb. Blood Flow Metab. 20:2000;82-92.
25. DeJong R.N. CNS manifestations of diabetes mellitus. Postgrad. Med. 61:1977;101-107.
26. Dey J., Misra A., Desai N.G., Mahapatra A.K., Padma M.V. Cognitive function in younger type II diabetes. Diabetes Care. 20:1997;32-35.
27. Di Mario U., Morano S., Valle E., Pozzessere G. Electrophysiological alterations of the central nervous system in diabetes mellitus. Diabetes Metab. Rev. 11:1995;259-277.
28. Donald M.W., Erdahl D.L., Surridge D.H., Monga T.N., Lawson J.S., Bird C.E., Letemendia F.J. Functional correlates of reduced central conduction velocity in diabetic subjects. Diabetes. 33:1984;627-633.
29. Du C., Hu R., Csernansky C.A., Hsu C.Y., Choi D.W. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J. Cereb. Blood Flow Metab. 16:1996;195-201.
30. Endres M., Namura S., Shimizu-Sasamata M., Waeber C., Zhang L., Gomez-Isla T., Hyman B.T., Moskowitz M.A. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. 18:1998;238-247.
31. Fadeel B., Orrenius S., Zhivotovsky B. Apoptosis in human disease: a new skin for the old ceremony? Biochem. Biophys. Res. Commun. 266:1999;699-717.
32. Fernqvist-Forbes E., Johansson B.L., Eriksson M.J. Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes mellitus. Acta Physiol. Scand. 172:2001;159-165.
33. Flood J.F., Mooradian A.D., Morley J.E. Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes. 39:1990;1391-1398.
34. Forst T., Kunt T., Pfutzner A., Beyer J., Wahren J. New aspects on biological activity of C-peptide in IDDM patients. Exp. Clin. Endocrinol. Diabetes. 106:1998;270-276.
35. Garris D.R. Diabetes-associated, ventromedial hypothalamic neuronal degeneration in the Chinese hamster. Neurosci. Lett. 44:1984;287-291.
36. Garris D.R., Diani A.R., Smith C., Gerritsen G.C. Depopulation of the ventromedial hypothalamic nucleus in the diabetic Chinese hamster. Acta Neuropathol. (Berl.). 56:1982;63-66.
37. Gerozissis K., Rouch C., Lemierre S., Nicolaidis S., Orosco M. A potential role of central insulin in learning and memory related to feeding. Cell. Mol. Neurobiol. 21:2001;389-401.
38. Gispen W.H., Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23:2000;542-549.
39. Gisselsson L., Smith M.L., Siesjö B.K. Hyperglycemia and focal brain ischemia. J. Cereb. Blood Flow Metab. 19:1999;288-297.
40. Gold A.E., Deary I.J., Jones R.W., O'Hare J.P., Reckless J.P., Frier B.M. Severe deterioration in cognitive function and personality in five patients with long-standing diabetes: a complication of diabetes or a consequence of treatment? Diabet. Med. 11:1994;499-505.
41. Gorman A.M., McGowan A., O'Neill C., Cotter T. Oxidative stress and apoptosis in neurodegeneration. J. Neurol. Sci. 139:1996;45-52. (Suppl.).
42. Gradman T.J., Laws A., Thompson L.W., Reaven G.M. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J. Am. Geriatr. Soc. 41:1993;1305-1312.
43. Grunberger G., Sima A.A.F. The C-peptide signaling. Exp. Diabetes Res. 5:2004;25-36.
44. Grunberger G., Qiang X., Li Z.-G., Mathews S.T., Sbriessa D., Shiskeva A., Sima A.A.F. Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia. 44:2001;1247-1257.
45. Harkins S.W., Gardner D.F., Anderson R.A. Auditory and somatosensory far-field evoked potentials in diabetes mellitus. Int. J. Neurosci. 28:1985;41-47.
46. Holmes C.S., Richman L.C. Cognitive profiles of children with insulin-dependent diabetes. J. Dev. Behav. Pediatr. 6:1985;323-326.
47. Huang D.Y., Richter K., Breidenbach A., Vallon V. Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study. Naunyn-Schmiedeberg's Arch. Pharmacol. 365:2002;67-73.
48. Ido Y., Vindigni A., Chang K., Stramm L., Chance R., Heath W.F., DiMarchi R.D., Di Cera E., Williamson J.R. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science. 277:1997;563-566.
49. Jakobsen J., Sidenius P., Gundersen H.J., Østerby R. Quantitative changes of cerebral neocortical structure in insulin-treated long-term streptozocin-induced diabetes in rats. Diabetes. 36:1987;597-601.
50. Jensen M.E., Messina E.J. C-peptide induces concentration-dependent dilatation of skeletal muscle arterioles only in the presence of insulin. Am. J. Physiol. 276:1999;H1223-H1228.
51. Johansson B.L., Sjöberg S., Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 insulin-dependent diabetic patients. Diabetologia. 35:1992;121-128.
52. Johansson B.L., Borg K., Fernqvist-Forbes E., Odergren T., Remahl S., Wahren J. C-peptide improves autonomic nerve function in IDDM patients. Diabetologia. 39:1996;687-695.
53. Kamal A., Biessels G.J., Urban I.J., Gispen W.H. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience. 90:1999;737-745.
54. Kamal A., Biessels G.J., Duis S.E., Gispen W.H. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia. 43:2000;500-506.
55. Kaminski K.A., Bonda T.A., Korecki J., Musial W.J. Oxidative stress and neutrophil activation - the two keystones of ischemia/reperfusion injury. Int. J. Cardiol. 86:2002;41-59.
56. Kitamura T., Kimura K., Jung B.D., Makondo K., Sakane N., Yoshida T., Saito M. Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem. J. 366:2002;737-744.
57. Kothari V., Stevens R.J., Adler A.I., Stratton I.M., Manley S.E., Neil H.A., Holman R.R. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke. 33:2002;1776-1781.
58. Kovacs M., Goldston D., Obrosky D.S., Bonar L.K. Psychiatric disorders in youths with IDDM: rates and risk factors. Diabetes Care. 20:1997;36-44.
59. Kramer L., Fasching P., Madl C., Schneider B., Damjancic P., Waldhäusl W., Irsigler K., Grimm G. Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes. 47:1998;1909-1914.
60. Kulikov A.V., Arkhipova L.V., Tretyak T.M., Bragin A.G. Serotonin and norepinephrine content in brain structures of rats with experimental and transplantation-compensated diabetes. J. Hirnforsch. 27:1986;495-499.
61. Kurita A., Mochio S., Isogai Y. Changes in auditory P300 event-related potentials and brainstem evoked potentials in diabetes mellitus. Acta Neurol. Scand. 92:1995;319-323.
62. Laing S.P., Swerdlow A.J., Carpenter L.M., Slater S.D., Burden A.C., Botha J.L., Morris A.D., Waugh N.R., Gatling W., Gale E.A., Patterson C.C., Qiao Z., Keen H. Mortality from cerebrovascular disease in a cohort of 23. 000 patients with insulin-treated diabetes Stroke. 34:2003;418-421.
63. Lee-Kwon W., Park D., Baskar P.V., Kole S., Bernier M. Antiapoptotic signaling by the insulin receptor in Chinese hamster ovary cells. Biochemistry. 37:1998;15747-15757.
64. Lehto S., Ronnemaa T., Pyorala K., Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke. 27:1996;63-68.
65. LeMay D.R., Gehua L., Zelenock G.B., D'Alecy L.G. Insulin administration protects neurologic function in cerebral ischemia in rats. Stroke. 19:1988;1411-1419.
66. Li Z.G., Sima A.A.F. C-peptide and CNS complications in diabetes. Exp. Diabetes Res. 5:2004;79-90.
67. Li Y., Sharov V.G., Jiang N., Zaloga C., Sabbah H.N., Chopp M. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am. J. Pathol. 146:1995;1045-1051.
68. Li P.A., Gisselsson L., Keuker J., Vogel J., Smith M.L., Kuschinsky W., Siesjö B.K. Hyperglycemia-exaggerated ischemic brain damage following 30 min of middle cerebral artery occlusion is not due to capillary obstruction. Brain Res. 804:1998;36-44.
69. Li L., Oshida Y., Kusunoki M., Yamanouchi K., Johansson B.L., Wahren J., Sato Y. Rat C peptide I and II stimulate glucose utilization in STZ-induced diabetic rats. Diabetologia. 42:1999;958-964.
70. Li Z.G., Qiang X., Sima A.A.F., Grunberger G. C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts. Biochem. Biophys. Res. Commun. 280:2001;615-619.
71. Li X., Aou S., Hori T., Oomura Y. Spatial memory deficit and emotional abnormality in OLETF rats. Physiol. Behav. 75:2002;15-23.
72. Li Z.G., Zhang W., Grunberger G., Sima A.A.F. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res. 946:2002;221-231.
73. Li Z.G., Zhang W., Sima A.A.F. C-peptide prevents hippocampal apoptosis in type 1 diabetes. Int. J. Exp. Diabetes Res. 3:2002;241-245.
74. Li Z.G., Zhang W., Sima A.A.F. C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells. Diabetes Metab. Res. Rev. 19:2003;375-385.
75. Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. J. Diabetes its Complicat. 15:2001;203-210.
76. Love S. Oxidative stress in brain ischemia. Brain Pathol. 9:1999;119-131.
77. Luesse H.G., Schiefer J., Spruenken A., Puls C., Block F., Kosinski C.M. Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus. Behav. Brain Res. 126:2001;185-195.
78. Lunetta M., Damanti A.R., Fabbri G., Lombardo M., Di Mauro M., Mughini L. Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients. J. Endocrinol. Invest. 17:1994;241-245.
79. Luo Y., Cao G., Pei W., O'Horo C., Graham S.H., Chen J. Induction of caspase-activated deoxyribonuclease activity after focal cerebral ischemia and reperfusion. J. Cereb. Blood Flow Metab. 22:2002;15-20.
80. Luse S.A. The ultrastructure of the brain in the diabetic Chinese hamster with special reference to synaptic abnormalities. Electroencephalogr. Clin. Neurophysiol. 29:1970;410.
81. Lustman P.J., Griffith L.S., Clouse R.E. Depression in adults with diabetes. Results of 5-yr follow-up study. Diabetes Care. 11:1988;605-612.
82. Madl C., Grimm G., Kramer L., Koppensteiner R., Hirschl M., Yeganehfar W., Hirschl M.M., Ugurluoglu A., Schneider B., Ehringer H. Cognitive brain function in non-demented patients with low-grade and high-grade carotid artery stenosis. Eur. J. Clin. Investig. 24:1994;559-564.
83. Manson J.E., Colditz G.A., Stampfer M.J., Willett W.C., Krolewski A.S., Rosner B., Arky R.A., Speizer F.E., Hennekens C.H. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch. Intern. Med. 151:1991;1141-1147.
84. McCarthy A.M., Lindgren S., Mengeling M.A., Tsalikian E., Engvall J.C. Effects of diabetes on learning in children. Pediatrics. 109:2002;E9.
85. Mercuri F., Quagliaro L., Ceriello A. Oxidative stress evaluation in diabetes. Diabetes Technol. Ther. 2:2000;589-600.
86. Miles W.R., Root H.F. Psychologic tests applied to diabetic patients. Arch. Int. Med. 30:1922;767-777.
87. Mochizuki Y., Oishi M., Hayakawa Y., Matsuzaki M., Takasu T. Improvement of P300 latency by treatment in non-insulin-dependent diabetes mellitus. Clin. Electroencephalogr. 29:1998;194-196.
88. Mooradian A.D. Central nervous system complications of diabetes mellitus - a perspective from the blood-brain barrier. Brain Res. Brain Res. Rev. 23:1997;210-218.
89. Mooradian A.D., Perryman K., Fitten J., Kavonian G.D., Morley J.E. Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies. Arch. Intern. Med. 148:1988;2369-2372.
90. Mukai N., Hori S., Pomeroy M. Cerebral lesions in rats with streptozotocin-induced diabetes. Acta Neuropathol. (Berl.). 51:1980;79-84.
91. Muranyi M., Fujioka M., He Q., Han A., Yong G., Csiszar K., Li P.A. Diabetes activates cell death pathway after transient focal cerebral ischemia. Diabetes. 52:2003;481-486.
92. Namura S., Zhu J., Fink K., Endres M., Srinivasan A., Tomaselli K.J., Yuan J., Moskowitz M.A. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18:1998;3659-3668.
93. Nicotera P., Ankarcrona M., Bonfoco E., Orrenius S., Lipton S.A. Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neurol. 72:1997;95-101.
94. Opara E.C. Oxidative stress, micronutrients, diabetes mellitus and its complications. J. R. Soc. Health. 122:2002;28-34.
95. Orrenius S. Apoptosis: molecular mechanisms and implications for human disease. J. Intern. Med. 237:1995;529-536.
96. Parisi V., Uccioli L. Visual electrophysiological responses in persons with type 1 diabetes. Diabetes Metab. Res. Rev. 17:2001;12-18.
97. Perlmuter L.C., Hakami M.K., Hodgson-Harrington C., Ginsberg J., Katz J., Singer D.E., Nathan D.M. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am. J. Med. 77:1984;1043-1048.
98. Perros P., Deary I.J., Sellar R.J., Best J.J., Frier B.M. Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care. 20:1997;1013-1018.
99. Picton T.W. The P300 wave of the human event-related potential. J. Clin. Neurophysiol. 9:1992;456-479.
100. Pierson C.R., Zhang W., Sima A.A.F. Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration. J. Neuropathol. Exp. Neurol. 62:2003;765-779.
101. Pietravalle P., Morano S., Cristina G., Mancuso M., Valle E., Annulli M.A., Tomaselli M., Pozzessere G., Di Mario U. Early complications in type 1 diabetes: central nervous system alterations preceded kidney abnormalities. Diabetes Res. Clin. Pract. 21:1993;143-154.
102. Popkin M.K., Callies A.L., Lentz R.D., Colon E.A., Sutherland D.E. Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus. Arch. Gen. Psychiatry. 45:1988;64-68.
103. Pozzessere G., Valle E., de Crignis S., Cordischi V.M., Fattapposta F., Rizzo P.A., Pietravalle P., Cristina G., Morano S., di Mario U. Abnormalities of cognitive functions in IDDM revealed by P300 event-related potential analysis. Comparison with short-latency evoked potentials and psychometric tests. Diabetes. 40:1991;952-958.
104. Reaven G.M., Thomson L.W., Nahum P., Haskins E. Relationship between hyperglycemia and cognitive junction in older NIDDM patients. Diabetes Care. 13:1990;16-21.
105. Reske-Nielsen E., Lundbaek K. Diabetic encephalopathy. Diffuse and focal lesions of the brain in long-term diabetics. Acta Neurol. Scand., Suppl. 4:1964;273-290.
106. Reske-Nielsen E., Lundbaek K., Rafeisen Q.J. Pathological changes in the central and peripheral nervous system of young long-term diabetics I. Diabetic encephalopathy. Diabetologia. 1:1965;233-241.
107. Rigler R., Pramanik A., Jonasson P., Kratz P., Jansson O., Nygren P.Å., Ståhl S., Ekberg K., Johansson B.-L., Uhlén S., Uhlén M., Jörnvall H., Wahren J. Specific binding of proinsulin C-peptide to human cell membranes. Proc. Natl. Acad. Sci. U. S. A. 96:1999;13318-13323.
108. Rubini R., Biasiolo F., Fogarolo F., Magnavita V., Martini A., Fiori M.G. Brainstem auditory evoked potentials in rats with streptozotocin-induced diabetes. Diabetes Res. Clin. Pract. 16:1992;19-25.
109. Ryan C.M. Neurobehavioral complications of type I diabetes. Examination of possible risk factors. Diabetes Care. 11:1988;86-93.
110. Ryan C.M., Geckle M. Why is learning and memory dysfunction in Type 2 diabetes limited to older adults? Diabetes Metab. Res. Rev. 16:2000;308-315.
111. Ryan C.M., Geckle M.O. Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care. 23:2000;1486-1493.
112. Ryan C.M., Williams T.M. Effects of insulin-dependent diabetes on learning and memory efficiency in adults. J. Clin. Exp. Neuropsychol. 15:1993;685-700.
113. Ryan C.M., Williams T.M., Finegold D.N., Orchard T.J. Cognitive dysfunction in adults with type 1 insulin-dependent diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia. 36:1993;329-334.
114. Samnegard B., Jacobson S.H., Jaremko G., Johansson B.L., Sjo quist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int. 60:2001;1258-1265.
115. Sastre J., Pallardo F.V., Vina J. Mitochondrial oxidative stress plays a key role in aging and apoptosis. IUBMB Life. 49:2000;427-435.
116. Schoenle E.J., Schoenle D., Molinari L., Largo R.H. Impaired intellectual development in children with Type I diabetes: association with HbA1c, age at diagnosis and sex. Diabetologia. 45:2002;108-114.
117. Schulz J.B., Weller M., Moskowitz M.A. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann. Neurol. 45:1999;421-429.
118. Schwartz M.W., Figlewicz D.P., Baskin D.G., Woods S.C., Porte D. Jr. Insulin in the brain: a hormonal regulator of energy balance. Endocr. Rev. 13:1992;387-414.
119. Sima A.A.F. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell. Mol. Life Sci. 60:2003;2445-2464.
120. Sima A.A.F. C-peptide and diabetic neuropathy. Expert Opin. Investig. Drugs. 12:2003;1471-1488.
121. Sima A.A.F. Physiological and pathophysiological significance of C-peptide actions. Exp. Diabetes Res. 2004;. (in press).
122. Sima A.A.F., Zhang W.X., Cherian P.V., Chakrabarti S. Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat. Diabetologia. 35:1992;602-607.
123. Sima A.A.F., Zhang W., Sugimoto K., Henry D., Li Z.-G., Wahren J., Grunberger G. C-peptide prevents and improves chronic type 1 diabetic neuropathy in the BB/Wor-rat. Diabetologia. 44:2001;889-897.
124. Sinclair A.J., Girling A.J., Bayer A.J. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly AWARE Study. Diabetes Res. Clin. Pract. 50:2000;203-212.
125. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 16:1993;434-444.
126. Starr J.M., Wardlaw J., Ferguson K., MacLullich A., Deary I.J., Marshall I. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry. 74:2003;70-76.
127. Steiner D.F., Rubenstein A.H. Proinsulin C-peptide - biological activity? Science. 277:1997;531-532.
128. Strachan M.W., Deary I.J., Ewing F.M., Frier B.M. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care. 20:1997;438-445.
129. Sullivan J.M., Alousi S.S., Hikade K.R., Bahu N.J., Rafols J.A., Krause G.S., White B.C. Insulin induces dephosphorylation of eukaryotic initiation factor 2alpha and restores protein synthesis in vulnerable hippocampal neurons after transient brain ischemia. J. Cereb. Blood Flow Metab. 19:1999;1010-1019.
130. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
131. Trulson M.E., Jacoby J.H., MacKenzie R.G. Streptozotocin-induced diabetes reduces brain serotonin synthesis in rats. J. Neurochem. 46:1986;1068-1072.
132. Tun P.A., Nathan D.M., Perlmuter L.C. Cognitive and affective disorders in elderly diabetics. Clin. Geriatr. Med. 6:1990;731-746.
133. Uberall M.A., Renner C., Edl S., Parzinger E., Wenzel D. VEP and ERP abnormalities in children and adolescents with prepubertal onset of insulin-dependent diabetes mellitus. Neuropediatrics. 27:1996;88-93.
134. Vannucci R.C., Vannucci S.J. Hypoglycemic brain injury. Semin. Neonatol. 6:2001;147-155.
135. Varsik P., Kucera P., Buranova D., Balaz M. Is the spinal cord lesion rare in diabetes mellitus? Somatosensory evoked potentials and central conduction time in diabetes mellitus. Med. Sci. Monit. 7:2001;712-715.
136. Verrotti A., Lobefalo L., Trotta D., Della Loggia G., Chiarelli F., Luigi C., Morgese G., Gallenga P. Visual evoked potentials in young persons with newly diagnosed diabetes: a long-term follow-up. Dev. Med. Child Neurol. 42:2000;240-244.
137. Voll C.L., Auer R.N. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect. J. Cereb. Blood Flow Metab. 11:1991;1006-1014.
138. Voll C.L., Auer R.N. Postischemic seizures and necrotizing ischemic brain damage: neuroprotective effect of postischemic diazepam and insulin. Neurology. 41:1991;423-428.
139. Wahren J., Johansson B.L. Ernst-Friedrich-Pfeiffer Memorial Lecture. New aspects of C-peptide physiology. Horm. Metab. Res. 30:1998;A2-A5.
140. Wahren J., Johansson B.L., Wallberg-Henriksson H. Does C-peptide have a physiological role? Diabetologia. 37(Suppl. 2):1994;S99-S107.
141. Wahren J., Johansson B.L., Wallberg-Henriksson H., Linde B., Fernqvist-Forbes E., Zierath J.R. C-peptide revisited - new physiological effects and therapeutic implications. J. Intern. Med. 240:1996;115-124.
142. Worrall G., Moulton N., Briffett E. Effect of type II diabetes mellitus on cognitive function. J. Fam. Pract. 36:1993;639-643.
143. Wu W., Oshida Y., Yang W.P., Li L., Ohsawa I., Sato J., Iwao S., Johansson B.L., Wahren J., Sato Y. Effect of C-peptide administration on whole body glucose utilization in STZ-induced diabetic rats. Acta Physiol. Scand. 157:1996;253-258.
144. Wuarin L., Namdev R., Burns J.G., Fei Z.J., Ishii D.N. Brain insulin-like growth factor-II mRNA content is reduced in insulin-dependent and non-insulin-dependent diabetes mellitus. J. Neurochem. 67:1996;742-751.
145. Yager J.Y. Hypoglycemic injury to the immature brain. Clin. Perinatol. 29:2002;651-674.
146. Zhang W., Yorek M., Pierson C.R., Murakawa Y., Breidenbach A., Sima A.A.F. Human C-peptide dose dependently prevents early neuropathy in the BB/Wor-rat. Int. J. Exp. Diabetes Res. 2:2001;187-193.
147. Zhao W.Q., Alkon D.L. Role of insulin and insulin receptor in learning and memory. Mol. Cell. Endocrinol. 177:2001;125-134.
148. Ziegler O., Guerci B., Algan M., Lonchamp P., Weber M., Drouin P. Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control. Diabetes Care. 17:1994;1141-1147.
149. Zierath J.R., Galuska D., Johansson B.L., Wallberg-Henriksson H. Effect of human C-peptide on glucose transport in in vitro incubated human skeletal muscle. Diabetologia. 34:1991;899-901.
150. Zierath J.R., Handberg A., Tally M., Wallberg-Henriksson H. C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia. 39:1996;306-313.